88 related articles for article (PubMed ID: 8496820)
1. Tertatolol, a new beta-blocker, is a serotonin (5-hydroxytryptamine1A) receptor antagonist in rat brain.
Prisco S; Cagnotto A; Talone D; De Blasi A; Mennini T; Esposito E
J Pharmacol Exp Ther; 1993 May; 265(2):739-44. PubMed ID: 8496820
[TBL] [Abstract][Full Text] [Related]
2. (-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.
Jolas T; Haj-Dahmane S; Lanfumey L; Fattaccini CM; Kidd EJ; Adrien J; Gozlan H; Guardiola-Lemaitre B; Hamon M
Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):453-63. PubMed ID: 7686633
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
[TBL] [Abstract][Full Text] [Related]
4. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
[TBL] [Abstract][Full Text] [Related]
5. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
Martin LP; Jackson DM; Wallsten C; Waszczak BL
J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
Adrien J; Lanfumey L; Gozlan H; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1989 Mar; 248(3):1222-30. PubMed ID: 2522986
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
9. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
[TBL] [Abstract][Full Text] [Related]
10. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus.
Dos Santos L; de Andrade TG; Zangrossi Junior H
Eur Neuropsychopharmacol; 2008 Apr; 18(4):286-94. PubMed ID: 17728111
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the 5-hydroxytryptamine (5-HT)1A receptor inverse agonists Rec 27/0224 and Rec 27/0074 on electrophysiological responses to 5-HT1A receptor activation in rat dorsal raphe nucleus and hippocampus in vitro.
Corradetti R; Mlinar B; Falsini C; Pugliese AM; Cilia A; Destefani C; Testa R
J Pharmacol Exp Ther; 2005 Oct; 315(1):109-17. PubMed ID: 15951403
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.
File SE; Gonzalez LE
Pharmacol Biochem Behav; 1996 May; 54(1):123-8. PubMed ID: 8728549
[TBL] [Abstract][Full Text] [Related]
14. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
[TBL] [Abstract][Full Text] [Related]
15. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
Dong J; de Montigny C; Blier P
J Pharmacol Exp Ther; 1998 Sep; 286(3):1239-47. PubMed ID: 9732384
[TBL] [Abstract][Full Text] [Related]
16. Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors.
Bermack JE; Debonnel G
J Psychopharmacol; 2007 Jan; 21(1):85-92. PubMed ID: 16533864
[TBL] [Abstract][Full Text] [Related]
17. Affinity of (+/-)-pindolol, (-)-penbutolol, and (-)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain.
Castro ME; Harrison PJ; Pazos A; Sharp T
J Neurochem; 2000 Aug; 75(2):755-62. PubMed ID: 10899952
[TBL] [Abstract][Full Text] [Related]
18. Toward brain imaging of serotonin 5-HT1A autoreceptor internalization.
Zimmer L; Riad M; Rbah L; Belkacem-Kahlouli A; Le Bars D; Renaud B; Descarries L
Neuroimage; 2004 Jul; 22(3):1421-6. PubMed ID: 15219613
[TBL] [Abstract][Full Text] [Related]
19. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes.
Nishio H; Inoue A; Nakata Y
Arch Int Pharmacodyn Ther; 1996; 331(2):189-202. PubMed ID: 8937629
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical identification of stereotypic burst-firing neurons in the rat dorsal raphe nucleus using juxtacellular labelling methods.
Hajós M; Allers KA; Jennings K; Sharp T; Charette G; Sík A; Kocsis B
Eur J Neurosci; 2007 Jan; 25(1):119-26. PubMed ID: 17241273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
